3-aminoindolyl derivatives

Drug – bio-affecting and body treating compositions – Designated organic active ingredient containing – Having -c- – wherein x is chalcogen – bonded directly to...

Patent

Rate now

  [ 0.00 ] – not rated yet Voters 0   Comments 0

Details

548251, C07D 31405

Patent

active

057031070

ABSTRACT:
The present invention is directed to a new class of 3-amido and 3-sulfamido-indolyl NMDA antagonists and their use in the treatment of a number of disease states.

REFERENCES:
patent: 4675332 (1987-06-01), Conner et al.
patent: 4748183 (1988-05-01), Cetenko et al.
patent: 4774240 (1988-09-01), Boshagen et al.
patent: 4851406 (1989-07-01), Meriens et al.
patent: 4960786 (1990-10-01), Salituro et al.
A. Monge et al., J. Heterocyclic Chem., 24, pp. 437-439 (1987).
A.S. Bailey et al., J.C.S. Perkin I, pp. 1602-1606.
J.T. Greenamyre, Arch Neurol., vol. 43, pp. 1058-1063 (1986).
J.W. Olney, Biol. Psychiatry 26, pp. 505-525 (1989).
M.B. Robinson et al., FASEB J. 1:446-455 (1987).
R.Dingledine et al., TIPS vol.11, 334-338 (1990).
Salituro et al., Chem. Abstracts., vol. 116, No. 83486a (1991).

LandOfFree

Say what you really think

Search LandOfFree.com for the USA inventors and patents. Rate them and share your experience with other people.

Rating

3-aminoindolyl derivatives does not yet have a rating. At this time, there are no reviews or comments for this patent.

If you have personal experience with 3-aminoindolyl derivatives, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and 3-aminoindolyl derivatives will most certainly appreciate the feedback.

Rate now

     

Profile ID: LFUS-PAI-O-202731

  Search
All data on this website is collected from public sources. Our data reflects the most accurate information available at the time of publication.